Atezolizumab for the treatment of advanced recurrent basal cell carcinoma and urothelial carcinoma of bladder: a case report

BACKGROUND: The use of checkpoint inhibitors has become increasingly important in the treatment of different cancers, including advanced muscle-invasive urothelial cancer and even in basal cell carcinoma. We present the case of a patient with advanced basal cell carcinoma and metastatic muscle-invas...

Descripción completa

Detalles Bibliográficos
Autores principales: Küronya, Zsófia, Danyi, Tímea, Balatoni, Tímea, Liszkay, Gabriella, Tóth, Erika, Biró, Krisztina, Géczi, Lajos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623930/
https://www.ncbi.nlm.nih.gov/pubmed/36316780
http://dx.doi.org/10.1186/s13256-022-03634-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623930/
https://www.ncbi.nlm.nih.gov/pubmed/36316780
http://dx.doi.org/10.1186/s13256-022-03634-x

Ejemplares similares